EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC 3.0

Evaluating Rivaroxaban for Thromboprophylaxis in Cancer Patients with Long-Term Venous Access Devices: A Retrospective Cohort Study

Bin Jia iD, Hui Lv, Ting Gong, Xin Wang, Qing Ma, Yaoyao Ren, Linlin Zhang, Diansheng Zhong

Vascular Health and Risk Management · 2025

DOI: 10.2147/vhrm.s550388 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Vascular Health and Risk Management, 2025. Verfasst von Bin Jia und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Lung Cancer, Tianjin Lung Cancer Center, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center fo…. Hauptthemen laut MEDLINE: Rivaroxaban, Neoplasms, Catheterization, Central Venous, Factor Xa Inhibitors. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RivaroxabanNeoplasmsCatheterization, Central VenousFactor Xa InhibitorsCatheterization, PeripheralCentral Venous CathetersCatheters, IndwellingUpper Extremity Deep Vein ThrombosisHumansRetrospective StudiesFemaleMaleMiddle AgedTime FactorsRisk FactorsAgedTreatment OutcomeRisk AssessmentAdult

Stichwörter der Autor:innen

anticoagulantcentral venous catheterneoplasmprophylaxisthrombosis

Substanzen

RivaroxabanFactor Xa Inhibitors

Autor:innen und Institutionen

  • Department of Lung Cancer, Tianjin Lung Cancer Center, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's C…
  • Department of Medical Oncology, Tianjin Medical University General Hospital, Heping, Tianjin, People's Republic of China.

ORCID-Profile: Bin Jia

Zitieren

APA

Jia, B., Lv, H., Gong, T., Wang, X., Ma, Q., Ren, Y., Zhang, L., & Zhong, D. (2025). Evaluating Rivaroxaban for Thromboprophylaxis in Cancer Patients with Long-Term Venous Access Devices: A Retrospective Cohort Study. Vascular Health and Risk Management. https://doi.org/10.2147/vhrm.s550388

Vancouver

Jia B, Lv H, Gong T, Wang X, Ma Q, Ren Y, et al. Evaluating Rivaroxaban for Thromboprophylaxis in Cancer Patients with Long-Term Venous Access Devices: A Retrospective Cohort Study. Vascular Health and Risk Management. 2025. doi:10.2147/vhrm.s550388

BibTeX
@article{Jia2025,
  author = {Jia, Bin and Lv, Hui and Gong, Ting and Wang, Xin and Ma, Qing and Ren, Yaoyao and Zhang, Linlin and Zhong, Diansheng},
  title = {Evaluating Rivaroxaban for Thromboprophylaxis in Cancer Patients with Long-Term Venous Access Devices: A Retrospective Cohort Study},
  journal = {Vascular Health and Risk Management},
  year = {2025},
  doi = {10.2147/vhrm.s550388}
}
Kostenlos starten →